Over 9 Lakh 'Precaution Doses' of COVID-19 Vaccine Administered on 1st Day

4,91,013 healthcare workers, 1,90,383 frontline workers, and 2,54,868 received their 'precaution dose' on Monday.

2 min read
Over 9 Lakh 'Precaution Doses' of COVID-19 Vaccine Administered on 1st Day

The Quint DAILY

For impactful stories you just can’t miss

By subscribing you agree to our Privacy Policy

Over 9 lakh 'precaution doses' were administered to eligible beneficiaries as India began administering the third jab of the COVID-19 vaccine to healthcare workers, frontline workers, and people aged 60 and above with comorbidities on Monday, 10 January.

A total of 4,91,013 healthcare workers, 1,90,383 frontline workers, and 2,54,868 received their 'precaution dose' on Monday, as per data provided by the Ministry of Health and Family Welfare.

Meanwhile, Prime Minister Narendra Modi tweeted, "India began administering Precaution Doses. Kudos to those who have got vaccinated today. I would request all those who are eligible to get vaccinated. As we all know, vaccination remains among the most effective means to fight COVID-19."


Those eligible for the precautionary dose are permitted to receive the third dose only nine months after having received the second dose of the COVID-19 vaccine.

The government had previously informed that the precautionary COVID-19 vaccine dose will be the same vaccine as has been given previously. There will be no mixing of vaccines yet.

The health ministry had also said that there is no need to register for the precautionary vaccine doses. This means that those who are eligible for the dose can directly take an appointment or walk into any vaccination centre.

There is, however, no information on when all the adults will be eligible for the third jab. Meanwhile, Assembly elections for five poll-bound states are round the corner, despite a surge in coronavirus cases.

3rd Covaxin Dose Holds Promise: ICMR

Meanwhile, a day ahead of the expansion of the vaccination drive, the Indian Council of Medical Research (ICMR) said that Covaxin's third dose holds promise.

"Third dose of Covaxin holds promise," the ICMR wrote in a tweet. The medical agency also reiterated the benefits of the booster dose, saying that there is reassuring information on the safety and immunogenicity of a Covaxin booster dose.

"Good neutralising antibody titre detected against homologous and heterologous SARS-CoV 2 variants following booster. Reactogenicity in both vaccine and placebo arm of the trial was minimal and comparable. No serious adverse events were reported."

India on Sunday, 9 January, recorded 1,59,632 new COVID-19 cases, 40,863 recoveries, and 327 deaths in the span of 24 hours. The country also confirmed 3,623 cases of the highly transmissible Omicron variant.

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

Read Latest News and Breaking News at The Quint, browse for more from coronavirus

Speaking truth to power requires allies like you.
Become a Member
3 months
12 months
12 months
Check Member Benefits
Read More
Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!
More News